-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TwdjdSnDdLSdCB98+2qBOFVBI0Z53RC8GMFpl6u+8ZtcXPY5KpEOse18wGZPbhsm xQXhcEDTtaq5R3276YLsAw== 0001179110-03-006085.txt : 20030821 0001179110-03-006085.hdr.sgml : 20030821 20030821124836 ACCESSION NUMBER: 0001179110-03-006085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030819 FILED AS OF DATE: 20030821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HORSCH LAWRENCE L CENTRAL INDEX KEY: 0001190700 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-33295 FILM NUMBER: 03859614 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORP STREET 2: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 017601537 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICALCV INC CENTRAL INDEX KEY: 0001144284 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 411717208 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 9725 SOUTH ROBERT TRAIL CITY: INVER GROVE HEIGHTS STATE: MN ZIP: 55077 BUSINESS PHONE: 6514523000 MAIL ADDRESS: STREET 1: 9725 SOUTH ROBERT TRAIL CITY: INVER GROVE HEIGHTS STATE: MN ZIP: 55077 4 1 edgar.xml FORM 4 - X0201 4 2003-08-19 0 0001144284 MEDICALCV INC MDCVU 0001190700 HORSCH LAWRENCE L 1404 HILLTOP RIDGE HOULTON WI 54082 1 0 0 0 Option to purchase Common Stock 0.70 2003-08-19 4 A 0 100000 0 A 2007-08-19 2013-08-19 Common Stock 100000 100000 D Granted pursuant to the Company's 2001 Equity Incentive Plan, which meets the requirements of Rule 16b-3. This option shall vest in full on August 19, 2007. This vesting may be accelerated to the extent of one-third of the shares purchasable under the option upon the occurrence of each of three performance measures: 1) the Company completes the sale of $6.0 million of debt or equity financing between August 19, 2003 and January 31, 2004; 2) the board of directors of the Company determines in good faith that any new product under development as of August 19, 2003 is authorized to move to the next phase of development on or before August 19, 2004; and 3) the bid price of the common stock of the Company exeeds $1.50 for at least ten consecutive trading days between August 19, 2003 and August 19, 2004. /s/ Traci Christensen, Attorney-in-fact 2003-08-21 -----END PRIVACY-ENHANCED MESSAGE-----